PanGen Biotech Inc. Stock Price

KOSDAQ:A222110 Community·₩78.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A222110 Share Price Performance

₩5,790.00

-380.00 (-6.16%)

₩5,790.00

-380.00 (-6.16%)

₩5,790.00

Fri, 21 Nov 25

Share Pricen/a

A222110 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks

1 Reward

View Full Analysis

PanGen Biotech Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 121.61
: 33.23%
: 10.74%
: 3.1%

View Full Analysis

About A222110

Founded: 1999
Employees: n/a
CEO: Jaeseung Yoon
WebsiteView website: www.pangen.com

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.